Riskpilot← Back to searchSign inGet full accessTermino C 7316 AB
ABIn liquidationOrg 5590334602Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151 employees
Revenue 2021
SEK 67K
-93% vs 2020
EBITDA margin
383.6%
+576% vs 2020
Equity ratio
82.0%
Financial strength
Net profit 2021
SEK 238K
+248% vs 2020
| Revenue | SEK 67K | -93% |
| EBITDA | SEK 257K | +576% |
| Net profit | SEK 238K | +248% |
| Total assets | SEK 239K | -23% |
| Equity | SEK 196K | +567% |
| Employees | 1 | — |
Legal name
Termino C 7316 AB
Org number
5590334602
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 november 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 710 | 1 157 | 798 | 975 | 67 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −31 | 352 | 171 | −54 | 257 |
| Depreciation & amort. | −127 | −127 | −123 | −123 | −0 |
| EBIT | −158 | 225 | 48 | −177 | 257 |
| Net financials | −19 | −14 | −10 | −12 | 3 |
| Profit before tax | −177 | 210 | 11 | −161 | 260 |
| Tax | −0 | −7 | −3 | −0 | −22 |
| Net profit | −177 | 203 | 8 | −161 | 238 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 459 | 565 | 479 | 312 | 239 |
| Equity | −92 | 111 | 119 | −42 | 196 |
| Long-term debt | 416 | 253 | 317 | 178 | 0 |
| Short-term debt | 135 | 201 | 15 | 176 | 43 |
| Total debt | 551 | 454 | 332 | 354 | 43 |
EBITDA margin
383.6%
This company
15.8%
Market median
+2328% vs market
20172021
Equity ratio
82.0%
This company
38.2%
Market median
+115% vs market
20172021
Return on equity
121.4%
This company
18.4%
Market median
+560% vs market
20172021
Net profit margin
355.2%
This company
8.1%
Market median
+4285% vs market
20172021
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20172021
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Liquidator | Liquidator | 2022 |
| Former (1) | ||
FJ Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 7316 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torbjörn Nordberg | Liquidator | 0 companies |
| Frida Josefin Berlin | Chief Executive Officer | 0 companies |
| Axel Magnus Berlin | Deputy Board Member | 0 companies |